A study of different doses of NPI-001 tablets in healthy volunteers compared to a placebo to examine if it is safe and whether it should be taken with food or without food
Phase 1
- Conditions
- Retinitis pigmentosa
- Registration Number
- ACTRN12618001001280
- Lead Sponsor
- acuity Pharmaceuticals Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method